The North AmericanCreatinine Measurement Market is expected to reach US$ 269.75millionin 2027from US$ 148.79 millionin 2019. The market is estimated to grow with a CAGR of 7.8% from 2020-2027.
The growth of the creatinine measurement market is attributed tothe increasing prevalence of chronic kidney disorders, growing geriatric population, and others.In recent years, the developments in the biotechnology sectors have accelerated due to the expansion of technological and engineering applications. The growth in biotechnology industry has enabled launches of various products based on bioengineering concepts. Thus, innovations have supported the introduction of various technically advanced systems and have enabled to improve healthcare facilities. Thus, technological factors are likely to foster the growth of the North America creatinine measurement market during the forecast period.
Various companies are focusing on the advancement of the Creatinine Measurementmarket. For instance, Abbott, Danaher, Siemens Healthineers, and Diazyme Laboratories, Inc.havedone recent developments for products.
The Jaffe’s Kinase method segment held the largest market share in the North American creatinine measurement market, which is attributed to the increasing adoption of this method due to extended range of advantages. Moreover, increasing prevalence of chronic kidney diseases coupled with growing awareness and availability of the product in considerable margins are projected to drive the growth of the segment during the forecast period.
The US registered as the fastest-growing region in the North American creatinine measurement market. The growth of the market in the US is attributed due to rising support from the government, increasing geriatric population, implementation of strategic marketing policies by major players, and increasing incidence of chronic kidney diseases.
American Society of Nephrology andUS the Food and Drug Administration are the major primary and secondary sources for the creatinine measurement market included in the report.
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 Research Report Guidance
1.3 Market Segmentation
1.3.1 North America Creatinine Measurement Market – By Product
1.3.2 North America Creatinine Measurement Market – By Type
1.3.3 North America Creatinine Measurement Market – By Sample Type
1.3.4 North America Creatinine Measurement Market – By End User
1.3.5 North America Creatinine Measurement Market – By Country
2. Creatinine Measurement Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Creatinine Measurement – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America
4.3 Expert Opinion
5. Creatinine Measurement – Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Prevalence of Chronic Kidney Disorders
5.1.2 Growing Geriatric Population
5.2 Market Restraints
5.2.1 Shift Toward Novel Biomarkers
5.3 Market Opportunities
5.3.1 Emerging Markets in Developing Countries
5.4 Future Trends
5.4.1 Point-of-Care Renal Functioning Testing
5.5 Impact Analysis
6. Creatinine Measurement Market – Regional Analysis
6.1 North America Creatinine Measurement Market Revenue Forecast And Analysis
7. Creatinine Measurement Market Analysis – By Product
7.1 Overview
7.2 Creatinine Measurement Market Revenue Share, by Product (2019 and 2027)
7.3 Kits
7.3.1 Overview
7.3.2 Kits: Creatinine Measurement Market – Revenue and Forecast to 2027 (US$ Million)
7.4 Reagents
7.4.1 Overview
7.4.2 Reagents: Creatinine Measurement Market – Revenue and Forecast to 2027 (US$ Million)
8. Creatinine Measurement Market – By Type
8.1 Overview
8.2 Creatinine Measurement Market, by Type, 2019 and 2027 (%)
8.3 Enzymatic Method
8.3.1 Overview
8.3.2 Enzymatic Method: Creatinine Measurement Market – Revenue and Forecast to 2027 (US$ Million)
8.4 Jaffe’s Kinetic Method
8.4.1 Overview
8.4.2 Jaffe’s Kinetic Method: Creatinine Measurement Market – Revenue and Forecast to 2027 (US$ Million)
9. Creatinine Measurement Market – By Sample Type
9.1 Overview
9.2 Creatinine Measurement Market, by Sample Type, 2019 and 2027 (%)
9.3 Blood or Serum
9.3.1 Overview
9.3.2 Blood or Serum: Creatinine Measurement Market – Revenue and Forecast to 2027 (US$ Million)
9.4 Urine
9.4.1 Overview
9.4.2 Urine: Creatinine Measurement Market – Revenue and Forecast to 2027 (US$ Million)
10. Creatinine Measurement Market Analysis – By End User
10.1 Overview
10.2 Creatinine Measurement Market, by End User (2019 and 2027)
10.3 Hospitals
10.3.1 Overview
10.3.2 Hospitals: Creatinine Measurement Market, Revenue and Forecast to 2027 (US$ Million)
10.4 Diagnostic Laboratories
10.4.1 Overview
10.4.2 Diagnostic Laboratories: Creatinine Measurement Market, Revenue and Forecast to 2027 (US$ Million)
10.5 Others
10.5.1 Overview
10.5.2 Others: Creatinine Measurement Market, Revenue and Forecast to 2027 (US$ Million)
11. Creatinine Measurement Market – Regional Analysis
11.1 North America: Creatinine Measurement Market
11.1.1 Overview
11.1.2 North America: Creatinine Measurement Market – Revenue and Forecast to 2027 (USD Million)
11.1.3 North America: Creatinine Measurement Market, by Product, 2018–2027 (USD Million)
11.1.4 North America: Creatinine Measurement Market, by Type, 2018–2027 (USD Million)
11.1.5 North America: Creatinine Measurement Market, by Sample Type, 2018–2027 (USD Million)
11.1.6 North America: Creatinine Measurement Market, by End User , 2018–2027 (USD Million)
11.1.7 North America: Creatinine Measurement Market, by Country, 2019 & 2027 (%)
11.1.8 US: Creatinine Measurement Market – Revenue and Forecast to 2027 (USD Million)
11.1.8.1 US: Creatinine Measurement Market – Revenue and Forecast to 2027 (USD Million)
11.1.8.2 US: Creatinine Measurement Market, by Product, 2018–2027 (USD Million)
11.1.8.3 US: Creatinine Measurement Market, by Type, 2018–2027 (USD Million)
11.1.8.4 US: Creatinine Measurement Market, by Sample Type, 2018–2027 (USD Million)
11.1.8.5 US: Creatinine Measurement Market, by End User, 2018–2027 (USD Million)
11.1.9 Canada: Creatinine Measurement Market – Revenue and Forecast to 2027 (USD Million)
11.1.9.1 Canada: Creatinine Measurement Market – Revenue and Forecast to 2027 (USD Million)
11.1.9.2 Canada: Creatinine Measurement Market, by Product, 2018–2027 (USD Million)
11.1.9.3 Canada: Creatinine Measurement Market, by Type, 2018–2027 (USD Million)
11.1.9.4 Canada: Creatinine Measurement Market, by Sample Type, 2018–2027 (USD Million)
11.1.9.5 Canada: Creatinine Measurement Market, by End User, 2018–2027 (USD Million)
11.1.10 Mexico: Creatinine Measurement Market – Revenue and Forecast to 2027 (USD Million)
11.1.10.1 Mexico: Creatinine Measurement Market – Revenue and Forecast to 2027 (USD Million)
11.1.10.2 Mexico: Creatinine Measurement Market, by Product, 2018–2027 (USD Million)
11.1.10.3 Mexico: Creatinine Measurement Market, by Type, 2018–2027 (USD Million)
11.1.10.4 Mexico: Creatinine Measurement Market, by Sample Type, 2018–2027 (USD Million)
11.1.10.5 Mexico: Creatinine Measurement Market, by End User, 2018–2027 (USD Million)
12. Creatinine Measurement Market– Industry Landscape
12.1 Overview
12.1.1 Recent Developments by Players in the Creatinine Measurement Market
13. Creatinine Measurement Market – Key Company Profiles
13.1 Siemens Healthineers AG
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Abbott
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Thermo Fisher Scientific Inc.
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 F. Hoffmann-La Roche Ltd
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Danaher
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Cayman Chemical
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Randox Laboratories Ltd
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Fujifilm Wako Pure Chemical Corporation
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Beijing Leadman Biochemical Co., Ltd.
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Shanghai Fosun Pharmaceutical GroupCo., Ltd.
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
13.11 Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
13.11.1 Key Facts
13.11.2 Business Description
13.11.3 Products and Services
13.11.4 Financial Overview
13.11.5 SWOT Analysis
13.11.6 Key Developments
13.12 Beijing Jiuqiang Biotechnology Co., Ltd.
13.12.1 Key Facts
13.12.2 Business Description
13.12.3 Products and Services
13.12.4 Financial Overview
13.12.5 SWOT Analysis
13.12.6 Key Developments
13.13 Diazyme Laboratories, Inc.
13.13.1 Key Facts
13.13.2 Business Description
13.13.3 Products and Services
13.13.4 Financial Overview
13.13.5 SWOT Analysis
13.13.6 Key Developments
13.14 Dialab GmbH
13.14.1 Key Facts
13.14.2 Business Description
13.14.3 Products and Services
13.14.4 Financial Overview
13.14.5 SWOT Analysis
13.14.6 Key Developments
13.15 Maccura Biotechnology Co.
13.15.1 Key Facts
13.15.2 Business Description
13.15.3 Products and Services
13.15.4 Financial Overview
13.15.5 SWOT Analysis
13.15.6 Key Developments
14. Appendix
14.1 About
14.2 Glossary of Terms
LIST OF TABLES
Table 1. North America Creatinine Measurement Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 2. North America Creatinine Measurement Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 3. North America Creatinine Measurement Market, by Sample Type – Revenue and Forecast to 2027 (USD Million)
Table 4. North America Creatinine Measurement Market, by End-User – Revenue and Forecast to 2027 (USD Million)
Table 5. US Creatinine Measurement Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 6. US Creatinine Measurement Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 7. US Creatinine Measurement Market, by Sample Type – Revenue and Forecast to 2027 (USD Million)
Table 8. US Creatinine Measurement Market, by End-User – Revenue and Forecast to 2027 (USD Million)
Table 9. Canada Creatinine Measurement Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 10. Canada Creatinine Measurement Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 11. Canada Creatinine Measurement Market, by Sample Type – Revenue and Forecast to 2027 (USD Million)
Table 12. Canada Creatinine Measurement Market, by End-User – Revenue and Forecast to 2027 (USD Million)
Table 13. Mexico Creatinine Measurement Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 14. Mexico Creatinine Measurement Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 15. Mexico Creatinine Measurement Market, by Sample Type – Revenue and Forecast to 2027 (USD Million)
Table 16. Mexico Creatinine Measurement Market, by End-User – Revenue and Forecast to 2027 (USD Million)
Table 17. Recent Developments in The Creatinine Measurement Market
Table 18. Glossary of Terms, Creatinine Measurement Market
The List of Companies - North America Creatinine Measurement Market
1. Abbott
2. Beijing Jiuqiang Biotechnology Co., Ltd.
3. Beijing Leadman Biochemical Co., Ltd.
4. Cayman Chemical
5. Danaher
6. Dialab GmbH
7. Diazyme Laboratories, Inc.
8. F. Hoffmann-La Roche Ltd
9. Fujifilm Wako Pure Chemical Corporation
10. Randox Laboratories Ltd
11. Shanghai Fosun Pharmaceutical Group Co., Ltd.
12. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
13. Siemens Healthineers AG
14. Thermo Fisher Scientific Inc.